LifeCell celebrates milestone achievement of 50,000 customers in Umbilical Cord Stem Cell Banking

~ A market leader as India’s largest and most accredited stem cell bank ~

banner

12 September 2012 :

LifeCell International, India’s largest and most accredited stem cell bank, announced a milestone achievement of successfully preserving 50,000 umbilical cord blood stem cell units in its preservation center and laboratory located in Chennai. Stem cells derived from the umbilical cord are known to have the potential to treat over 75 serious medical conditions. More and more expectant parents are now banking with LifeCell to collect and preserve their baby’s umbilical cord stem cells at birth for potential need in the future.

Established in 2004, LifeCell is India’s first private stem cell storage company and still retains the position of being the market leader with over 50,000 parents including some of the most popular celebrity couples having stored their baby’s umbilical cord stem cells with it. With a pan-India presence, LifeCell’s services extend to over 100 towns and cities in the country. Its preservation facility in Chennai is one of the most reputed in the industry with several national and international accreditations to its credit.

LifeCell has attained its stature as India’s largest stem cell preservation company through its persistent educative and promotional initiatives to create awareness on the need for stem cell preservation. To further enhance awareness, LifeCell partnered with Lisa Ray, Model and actor, who had undergone successful stem cell therapy for treatment of blood cancer. Lisa Ray continues to endorse the brand. LifeCell today enjoys the premium space in stem cell banking industry through its brand initiatives. Whilst India is the world’s largest birthing country, the penetration of the stem cell storage has been a dismal 0.2% compared to the global average which is between 5% in the US to as high as 25% in Singapore. LifeCell believes that poor awareness rate and per capita income are the primary reasons for low penetration in the Indian market, yet is optimistic that India would soon reach the global benchmarks.

Commenting on the milestone achievement, Mr Mayur Abhaya, Managing Director and CEO said, “When we launched our services in 2004 the medical fraternity was not even aware of the concept of stem cell banking. It was our responsibility to create awareness amongst both the doctors and the expectant parents about its enormous scope in the future. As a first step we dedicatedly imparted education at medical forums and put together an experience customer detailing team who counseled parents on a one-to-one level inside the comfort of their homes. Our 50,000 member milestone is recognition of that effort. I’m pleased that we are now offering this valuable service pan India and increasingly in other neighbouring countries too”.

The stem cell storage industry is growing at a rate of 30-40% per year. More and more innovative services have been launched in the space of stem cell preservation such menstrual blood banking. To address the market opportunity LifeCell has embarked on significantly expanding its preservation capacity at its facility in Chennai expected to be completed in the next 3 months.

About LifeCell International

LifeCell is India’s largest & most accredited stem cell bank and the first to bring the revolutionary concept of umbilical cord stem cell banking to India in 2004 in technological collaboration with Cryo-Cell International USA -the world’s first private stem cell bank. LifeCell is headquartered at Chennai with an advanced laboratory & research facility in adherence to strict International guidelines. The stringent standards followed by LifeCell have received many International accreditations from AABB (American Association of Blood Banks), CAP (College of American Pathologists), and NABL (National Accreditation Board for Calibration and Testing Laboratories). LifeCell is the first stem cell bank in India to receive prestigious AABB accreditation for Cord blood & cord tissue. Importantly LifeCell is also the second in the world to be accredited for cord tissue preservation. Since inception LifeCell has grown at a consistent pace and has strongly established its leadership position in the industry, with its coverage extending to over 100 cities and towns in India. As leaders LifeCell had the responsibility of educating the public and medical fraternity on stem cell technology and through these efforts today over 50,000 parents have preserved their baby’s cord blood stem cells with LifeCell. Considering LifeCell’s leadership position and growth, the company was honoured as one amongst ‘India’s Most Promising Brand’ for 2011-2012 by 4Ps Business and Marketing.

The company is also championing several initiatives in the stem cell therapy area through partnerships and in-house R&D efforts. LifeCell is the sole distributor for USFDA approved point-of-care medical device that can provide a patient’s stem cells from the bone marrow within 15 minutes from by the bed-side, which is useful for applications in orthopaedic, vascular and cardiovascular specialities.. With these significant achievements and leadership, LifeCell has uniquely positioned itself as a comprehensive stem cells solutions provider with a complete spectrum of services in stem cells through multi-service stem cell banking, R&D, clinical trials and stem cell therapy.

For more information log onto: http://www.lifecellinternational.com

Media Contacts: LifeCell International

V. Ravi Shankar,

Head – Corporate Communications & Marketing ravishankar.v@lifecellinternational.com Handphone: 096770 03344

Edelman India

Pallavi Walia / Shruti Bose

Handphone: 07738190811, 9769479229

Pallavi.Walia@edelman.com, Shruti.Bose@edelman.com

top stories

A loving father expresses his gratitude this Father’s Day!

The loving father of lil' Noah who recovered from a rare condition with stem cells devotes his entire life to convince new mothers to preserve their baby’s stem cells..

Read More


top stories

LifeCell acquires 100% ownership stake in subsidiary Fetomed Laboratories

Consolidates presence in preventive diagnostics for mother & baby healthcare

Read More